Status:
UNKNOWN
Evaluation of Trans-Hepatic Flow Changes in Major Hepatectomy
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Major Hepatectomy
Eligibility:
All Genders
18+ years
Brief Summary
Changes in trans-hepatic flow after major and extended hepatectomy (EH) can lead to small for size and flow syndrome (SFSF), which is associated with a significantly higher rate of morbidity and morta...
Detailed Description
Liver resection is an efficient treatment for primary and secondary hepatic tumors and increases long term survival. Improvements in patient selection criteria, surgical methods, and postoperative car...
Eligibility Criteria
Inclusion
- Patient consent
- Undergoing major or central liver resection
- Aged above 18 years
Exclusion
- Cirrhosis
- Previous surgery of the hepatoduodenal ligament
- Status after transjugular intrahepatic portosystemic shunt
- Metabolic liver diseases
- Cardiac failure
- Pulmonary hypertension
- Portal vein thrombosis
- Portal vein hypertension
- Vascular malformation
- Not able to give consent
Key Trial Info
Start Date :
March 25 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03762876
Start Date
March 25 2018
End Date
July 1 2020
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Visceral Transplantation, Department of General, Visceral and Transplantation Surgery, University of Heidelberg
Heidelberg, Baden-Wurttemberg, Germany, 69120